Announced Thu, 28 May · 16:22 IST

This is in continuation to our intimation dated May 27, 2026, we are hereby submitting the Revised Board Meeting Outcome. The revised outcome includes corrections to typographical errors ....

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.2%1-day move
₹2.33
prior close
₹2.33
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-0.9+0.4+0.0-5.2-5.6-7.3-8.2-8.6-9.9-2.6-9.4
Up moveDown movePending
AI summary

Deep Health AI India Ltd has filed a revised board meeting outcome correcting typographical errors from their earlier May 27, 2026 filing. The company's Board of Directors meeting held on May 27, 2026 (2:00 PM to 9:50 PM) has deferred the consideration and approval of Audited Standalone and Consolidated Financial Results for FY ended March 31, 2026. The company cited 'paucity of time' and the need to seek further clarifications from Management as reasons for the deferral. The matter has been rescheduled to Friday, May 29, 2026.

Likely market impact

The deferral of financial results approval may create short-term uncertainty for investors. While the results are only delayed by two days, the need for additional management clarifications could suggest underlying concerns with the financials that warrant attention once results are released.